Miriam S. Butler

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.

Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer.

Journal: Cell chemical biology

Published: July 06, 2022

Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients.

Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients.

Journal: Histopathology

Published: September 19, 2019

HBO1 is required for the maintenance of leukaemia stem cells.

HBO1 is required for the maintenance of leukaemia stem cells.

Journal: Nature

Published: September 05, 2018

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance.

Journal: Oncotarget

Published: October 15, 2016

Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.

Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.

Journal: Oncotarget

Published: July 29, 2016

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.

Journal: Oncogene

Published: June 28, 2016

Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in Mice.

Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in Mice.

Journal: Scientific reports

Published: January 04, 2016

Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.

Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.

Journal: Cancer treatment reviews

Published: March 20, 2014

In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.

In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.

Journal: Breast cancer research : BCR

Published: February 12, 2014

SGTA: a new player in the molecular co-chaperone game.

SGTA: a new player in the molecular co-chaperone game.

Journal: Hormones & cancer

Published: April 29, 2013

Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.

Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.

Journal: Hormones & cancer

Published: November 08, 2012

Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.

Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.

Journal: Fertility and sterility

Published: November 24, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026